Andere Kunden interessierten sich auch für
![Mammary carcinoma]( "Mammary carcinoma")
Mammary carcinoma22,99 €![Alterations in Mammary Epithelial Cell Identity]( "Alterations in Mammary Epithelial Cell Identity")
Alterations in Mammary Epithelial Cell Identity32,99 €![Metaplastic carcinoma of the breast]( "Metaplastic carcinoma of the breast")
Metaplastic carcinoma of the breast26,99 €![Immunophenotyping of mammary carcinoma]( "Immunophenotyping of mammary carcinoma")
Immunophenotyping of mammary carcinoma29,99 €![Hematologic alterations and risk factors]( "Hematologic alterations and risk factors")
Hematologic alterations and risk factors29,99 €![CARDIOVASCULAR ALTERATIONS IN THE ADULT PATIENT WITH SICKLE CELL DISEASE.]( "CARDIOVASCULAR ALTERATIONS IN THE ADULT PATIENT WITH SICKLE CELL DISEASE.")
CARDIOVASCULAR ALTERATIONS IN THE ADULT PATIENT WITH SICKLE CELL DISEASE.29,99 €![Vitamin D3 Levels in Adults with Obesity, What is the relationship?]( "Vitamin D3 Levels in Adults with Obesity, What is the relationship?")
Vitamin D3 Levels in Adults with Obesity, What is the relationship?26,99 €
Breast carcinoma is a multicausal disease. Metabolic alterations at the diagnosis of breast carcinoma were related to the clinical-tumor characteristics of the patients. An observational-analytical and cross-sectional research was carried out with 155 patients with breast cancer diagnosed in 2019 in Pinar del Río. The documentary analysis allowed obtaining demographic data and characteristics. Patients with overweight-obesity and normoglycemia were predominant. No association was found between high BMI and menopausal status at the time of diagnosis. Overweight-obesity was associated with the stage of the disease in postmenopausal women and represented a protective factor in relation to the estrogen receptor type of the tumor in premenopausal women.